Response of apolipoprotein AIV and lipoproteins to glycaemic control in young people with insulin-dependent diabetes mellitus

Diabetic Medicine

Volumn 14, Issue 3, 1997, Pages 242-247

  Attia, N ^a   Touzani, A ^b   Lahrichi, M ^b   Balafrej, A ^c   Kabbaj, O ^b   Girard Globa, A ^a,d  

^a Lab de Rech en Pathol Infectieuse   (France)

^b MOHAMMED V UNIVERSITY   (Morocco)

^c Hopital d'Enfants   (Morocco)

^d Lab Metabolisme Lipides CNRS U   (France)

Author keywords

apolipoprotein AIV; apolipoprotein B; cholesterol; insulin dependent diabetes mellitus; triglyceride

Indexed keywords

APOLIPOPROTEIN A4; APOLIPOPROTEIN B; CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS A; APOLIPOPROTEINS B; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; LIPOPROTEINS; MALE; PHOSPHOLIPIDS; REFERENCE VALUES; REGRESSION ANALYSIS; SEX CHARACTERISTICS; TIME FACTORS; TRIGLYCERIDES;

EID: 0030943159     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199703)14:3<242::AID-DIA340>3.0.CO;2-1     Document Type: Article

References (44)

1. Garcia MJ, McNamara PM, Gordon T, Kannell WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 1974; 23: 105-111.
2. Palumbo PJ, Elveback LR, Chu CP, Connolly DC, Kurland LT. Diabetes mellitus: incidence, prevalence, survivorship, and causes of death in Rochester, Minnesota 1945-1970. Diabetes 1976; 25: 556-573.
3. Chance GW, Alberitt EC, Adkins SM. Serum lipids and lipoproteins in untreated diabetic children. Lancet 1969; 1: 1126-1128.
4. Bonadonna RC, Groop LC, Zych K, Shank M, DeFronzo RA. Dose dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans. Am J Physiol 1990; 259: E736-E750.
5. Taskinen MR. Lipoprotein lipase in diabetes. Diab Metab Rev 1987; 3: 551-570.
6. Pietri AO, Dunn FL, Raskin P, Grundy SM. The effect of continuous subcutaneous insulin infusion on very low density lipoprotein triglyceride metabolism in type I diabetes mellitus. Diabetes 1983; 32: 75-81.
7. Lopez-Virella MF, Wohltmann HJ, Loadholt CB, Buse MG. Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control. Diabetologia 1981; 21: 216-223.
8. Gonen B, White N, Schonfeld G, Skor D, Miller P, Santiago J. Plasma levels of apoprotein B in patients with diabetes mellitus: the effect of glycemia control. Metabolism 1985; 34: 675-679.
9. Strobl W, Widhalm K, Schober E. Apoplipoproteins and lipoproteins in children with type I diabetes: relation to glycosylated serum protein and HbA1c. Acta Paediatr Scand 1985; 74: 966-971.
10. Ostlund RE Jr, Semenhovich CF, Schechtman KB. Quantitative relationship between plasma lipids and glycohemoglobin in type I Diabetes. Diabetes Care 1989; 12: 332-336.
11. Sosenko JM, Breslow JL, Miettinen OS. Hyperglycaemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients. N Engl J Med 1980; 302: 650-654.
12. Mattock MB, Fuller JH, Maude PS, Keen H. Lipoproteins and plasma cholesterol esterification in normal and diabetic subjects. Atherosclerosis 1979; 34: 439-449.
13. Brunzell JD, Chait A, Bierman E. Plasma lipoproteins in human diabetes mellitus. In: The Diabetes Annual. K.G.M.M. Alberti and L.D. Krall editors. Amsterdam: Elsevier, 1985: 463-479.
14. Kennedy AL, Lappin TRJ, Lavery JD, Madden DR, Weaver JA, Montgomery DAD. Relation of high density lipoprotein cholesterol concentration to type I of diabetes and its control. Br Med J 1978; 2: 1191-1194.
15. Nikkila EA, Hormila P. Serum lipids and lipoproteins in insulin-treated diabetics. Demonstration of increased high density lipoprotein concentrations. Diabetes 1978; 27: 1078-1085.
16. Mattock MB, Salter AM, Fuller JH, Omer T, El-Gohari R, Redmond SD, Keen H. High density lipoprotein subfractions in insulin-dependent diabetic and normal subjects. Atherosclerosis 1982; 45: 67-79.
17. Durrington PN. Serum high density lipoprotein cholesterol subfractions in type I (insulin-dependent) diabetes mellitus. Clin Chim Acta 1982; 120: 21-28.
18. Laakso ME, Voutilainen E, Surlund H, Aro A, Pyorala K, Pentilla I. Inverse relationship of serum HDL and HDL2 cholesterol to C-peptide level in middle-aged insulin treated diabetics. Metabolism 1985; 34: 715-720.
19. Taskinen MR, Kuusi T, Nikkila EA. Regulation of HDL and its subfractions in chronically insulin-treated patients with type I diabetes. In: Diabetes, Obesity and Hyperlipidemias. G. Crepaldi et al, editors. Amsterdam: Elsevier, 1985; 251-259.
20. Al Muhtaseb N, Al Yousuf AR, Bajaj JS. Apolipoprotein AI, All, B, CII, and CIII in children with insulin-dependent diabetes mellitus. Pediatrics 1992; 89: 936-941.
21. Glasgow AM, August GP, Hung W. Relationship between control and serum lipids in juvenile-onset diabetes. Diabetes Care 1981; 4: 76-80.
22. Lopez-Virella MF, Sherer GK, Lees AM, Wohltmann H, Mayfield R, Sagel J et al. Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type I (insulin-dependent) diabetic patients: changes with metabolic control. Diabetologia 1982; 22: 430-436.
23. Lopez-Virella MF, Sherer G, Wohltmann H, Sens D, Colwell JA. Diabetic lipoprotein deficient serum: its effect in low density lipoprotein uptake and degradation by fibroblasts. Metabolism 1985; 34: 1079-1080.
24. Cruickshanks KJ, Orchard TJ, Becker DJ. The cardiovascular risk profile of adolescents with insulin-dependent diabetes mellitus. Diabetes Care 1985; 8: 118-124.
25. Dullaart FPF, Groener JEM, Dikkaschei LD, Erkelens DW, Doorenbus H. Increased cholesteryl ester transfer activity in complicated type I (insulin-dependent) diabetes mellitus: its relationship with serum lipids. Diabetologia 1989; 32: 14-19.
26. Bagdade JD, Subbaiah PV, Ritter MC. Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus. Eur J Clin Invest 1991; 21: 161-167.
27. Green PHR, Glickman RM. Intestinal lipoprotein metabolism. J Lipid Res 1981; 22: 1153-1173.
28. Green PHR, Glickman RM, Riley JW, Quinet E. Human apolipoprotein A-IV: intestinal origin and distribution in plasma. J Clin Invest 1980; 665: 911-919.
29. Lagrost L, Gambert P, Meunier S, Morgado P, Desgres J, d'Athis P, Lallemant C. Correlation between apolipoprotein AIV and triglyceride concentration in human sera. J Lipid Res 1989; 30: 701-710.
30. Ushida E, Masumato A, Sakamoto S, Koga S, Nwata H. Effect of insulin, glucagon or dexamethasone on the production of apolipoprotein AIV in cultured hepatocytes. Aterhosclerosis 1991; 87: 195-202.
31. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T. Coronary heart disease in young Type I (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 1987; 30: 144-148.
32. Atger V, Wirbel E, Roche D, Apfelbaum M, Bursteín M, Girard-Globa ??. Distribution of HDL2 and HDL3 in a random population of healthy French males and females. Evaluation by a two-step procedure. Clin Chim Acta 1990; 189: 111-122.
33. Weinberg RB, Scann AM. Isolation and characterization of human apolipoprotein AIV from lipoprotein deplated serum. J Lipid Res 1983; 24: 52-59.
34. Nikkila EA, Mekki M. Plasma triglyceride transport kinetics in diabetes mellitus. Metabolism 1973; 22: 1-22.
35. Rosenstock J, Vega GL, Raskin P. Improved diabetic control decreases LDL apo B synthesis in type I diabetes mellitus. Arteriosclerosis 1985; 5: 513A.
36. Berenson GS, Srinivasan SR, Skear CL, Webber LS. Risk factors in early life as prodictors of adult heart disease: the Bogalusa heart study. Am J Am Med Sci 1989; 298: 141-151.
37. Schaefer EJ, Foster DM, La Zech, Lindgren FT, Brewer Jr HB, Levy RI. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J Endocrinol Metab 1983; 57: 262-267.
38. Ewald U, Gustafson S, Tuvemo T, Vessby B. Increased high density lipoproteins in diabetic children. Eur J Pediatr 1984; 142: 154-156.
39. Eckel RH, Albers JJ, Cheung MC, Wahl PW, Lindgren FT, Bierman EL. High density lipoprotein composition in insulin-dependent diabetes mellitus. Diabetes 1981; 30: 132-138.
40. Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ. Postprandial lipoprotein changes in human subjects of different ages. J Lipid Res 1988; 29: 469-479.
41. Masumoto A, Koga S, Uchida E, Ibayashi A. Effects of insulin dexamethasone and glucagon on the production of apo Al in cultured rat hepatocytes. Atherosclerosis 1988; 70: 217-223.
42. Risser TR, Reaven GM, Reaven EP. Intestinal very low density lipoprotein secretion in insulin-deficient rats. Diabetes 1978; 27: 902-908.
43. Steinmetz A, Uterman G. Activation of lecithin cholesterol acyltransferase by human apo AIV. J Biol Chem 1985; 260: 2258-2264.
44. Ohta T, Fidge NH, Nestel PJ. Studies on the in vivo and in vitro distribution of apo AIV in human plasma and lymph. J Clin Invest 1985; 76: 1252-1260.